Finally, based on the expression levels and on topological considerations of miRNAs and clock genes, we selected miR-139-5p and TIMELESS to be further validated, in vitro, in a new cohort of CRC patients and in human colon cancer cell lines. This evidence concerns the gene CLOCK and malignant colon neoplasm.